Info

M&A Science

M&A Science is a podcast exploring the intricate world of mergers and acquisitions with industry leaders and practitioners. With an unlimited access to our deal network, these interviews examine M&A trends, culture, and best practices. This podcast is sponsored by DealRoom, an M&A lifecycle management platform.
RSS Feed Subscribe in Apple Podcasts
M&A Science
2024
May
April
March
February
January


2023
December
November
October
September
August
July
June
May
April
March
February
January


2022
December
November
October
September
August
July
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April


2018
July
June
May
February


2017
December
September
March
February


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
Jun 19, 2023

Finn Haley, SVP, Corporate Development at Edwards Lifesciences (NYSE:EW)

This episode is sponsored by the M&A Science Academy, DealRoom, and FirmRoom. 

To join our growing online community of M&A practitioners, visit https://www.mascience.com/academy. Don’t forget to use code “podcast” at checkout. 

Ready to take your M&A to the next level with software made to manage each stage of the deal process? See how DealRoom can facilitate your next deal at https://www.dealroom.net  

FirmRoom provides 80% cost savings over VDRs that bill by page and delivers a far better user experience to boot. Sign up in under 2 minutes by going to https://www.firmroom.com

Episode Timestamps

00:00 Intro

08:53 Option structure

14:04 Exit cap

16:11 Drivers for the structure

18:28 Alignment with the strategy

20:35 Monitoring progress and milestones

22:16 Moving fast

24:08 Failed startups

26:16 Risks

30:09 Exercising the option

33:54 Why deals don’t push through

38:53 Innovation

40:13 Approaching a company for the buy-to-build option structure

43:20 Craziest thing in M&A

 

0 Comments
Adding comments is not available at this time.